nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—HTR2A—chronic obstructive pulmonary disease	0.39	1	CbGaD
Donepezil—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0449	0.123	CbGbCtD
Donepezil—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0449	0.123	CbGbCtD
Donepezil—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0411	0.113	CbGbCtD
Donepezil—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0411	0.113	CbGbCtD
Donepezil—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0366	0.1	CbGbCtD
Donepezil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0345	0.0944	CbGbCtD
Donepezil—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.034	0.0933	CbGbCtD
Donepezil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0233	0.0638	CbGbCtD
Donepezil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0222	0.0608	CbGbCtD
Donepezil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0198	0.0542	CbGbCtD
Donepezil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0116	0.0318	CbGbCtD
Donepezil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.011	0.0301	CbGbCtD
Donepezil—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00858	0.516	CbGeAlD
Donepezil—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00311	0.187	CbGeAlD
Donepezil—Moexipril—ACE—chronic obstructive pulmonary disease	0.00179	1	CrCbGaD
Donepezil—SIGMAR1—bronchus—chronic obstructive pulmonary disease	0.000809	0.0487	CbGeAlD
Donepezil—SIGMAR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000792	0.0477	CbGeAlD
Donepezil—SIGMAR1—trachea—chronic obstructive pulmonary disease	0.000727	0.0437	CbGeAlD
Donepezil—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000524	0.0315	CbGeAlD
Donepezil—SIGMAR1—lung—chronic obstructive pulmonary disease	0.000522	0.0314	CbGeAlD
Donepezil—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000461	0.0278	CbGeAlD
Donepezil—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000422	0.0254	CbGeAlD
Donepezil—HTR2A—trachea—chronic obstructive pulmonary disease	0.000387	0.0233	CbGeAlD
Donepezil—HTR2A—lung—chronic obstructive pulmonary disease	0.000278	0.0167	CbGeAlD
Donepezil—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.00587	CbGpPWpGaD
Donepezil—ACHE—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000199	0.00563	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000196	0.00555	CbGpPWpGaD
Donepezil—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00019	0.00538	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000189	0.00536	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000188	0.00533	CbGpPWpGaD
Donepezil—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000187	0.0053	CbGpPWpGaD
Donepezil—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000179	0.00509	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000178	0.00504	CbGpPWpGaD
Donepezil—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.00504	CbGpPWpGaD
Donepezil—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00482	CbGpPWpGaD
Donepezil—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000845	CcSEcCtD
Donepezil—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000845	CcSEcCtD
Donepezil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000162	0.000844	CcSEcCtD
Donepezil—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000842	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000161	0.00457	CbGpPWpGaD
Donepezil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000161	0.000841	CcSEcCtD
Donepezil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.000841	CcSEcCtD
Donepezil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000161	0.00084	CcSEcCtD
Donepezil—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00084	CcSEcCtD
Donepezil—ACHE—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000161	0.00456	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00016	0.00454	CbGpPWpGaD
Donepezil—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000835	CcSEcCtD
Donepezil—Infection—Montelukast—chronic obstructive pulmonary disease	0.00016	0.000835	CcSEcCtD
Donepezil—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000834	CcSEcCtD
Donepezil—ACHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.000159	0.00451	CbGpPWpGaD
Donepezil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.00083	CcSEcCtD
Donepezil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000826	CcSEcCtD
Donepezil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000158	0.000824	CcSEcCtD
Donepezil—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000158	0.000823	CcSEcCtD
Donepezil—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.000822	CcSEcCtD
Donepezil—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000821	CcSEcCtD
Donepezil—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.00444	CbGpPWpGaD
Donepezil—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.00443	CbGpPWpGaD
Donepezil—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000813	CcSEcCtD
Donepezil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00081	CcSEcCtD
Donepezil—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000805	CcSEcCtD
Donepezil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.000801	CcSEcCtD
Donepezil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000154	0.000801	CcSEcCtD
Donepezil—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000801	CcSEcCtD
Donepezil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.000797	CcSEcCtD
Donepezil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000797	CcSEcCtD
Donepezil—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000796	CcSEcCtD
Donepezil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000794	CcSEcCtD
Donepezil—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00079	CcSEcCtD
Donepezil—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.00426	CbGpPWpGaD
Donepezil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.000783	CcSEcCtD
Donepezil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000783	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00015	0.000781	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.000781	CcSEcCtD
Donepezil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000776	CcSEcCtD
Donepezil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000776	CcSEcCtD
Donepezil—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000772	CcSEcCtD
Donepezil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.000771	CcSEcCtD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000147	0.00417	CbGpPWpGaD
Donepezil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000147	0.000765	CcSEcCtD
Donepezil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000765	CcSEcCtD
Donepezil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000765	CcSEcCtD
Donepezil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000762	CcSEcCtD
Donepezil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000762	CcSEcCtD
Donepezil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00076	CcSEcCtD
Donepezil—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000757	CcSEcCtD
Donepezil—ACHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000145	0.00411	CbGpPWpGaD
Donepezil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000757	CcSEcCtD
Donepezil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.000755	CcSEcCtD
Donepezil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000145	0.000755	CcSEcCtD
Donepezil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000145	0.000754	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000144	0.00408	CbGpPWpGaD
Donepezil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.000752	CcSEcCtD
Donepezil—HTR2A—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.000143	0.00406	CbGpPWpGaD
Donepezil—Injury—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000747	CcSEcCtD
Donepezil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000143	0.000747	CcSEcCtD
Donepezil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000143	0.000745	CcSEcCtD
Donepezil—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000743	CcSEcCtD
Donepezil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00074	CcSEcCtD
Donepezil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00074	CcSEcCtD
Donepezil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000142	0.000739	CcSEcCtD
Donepezil—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000739	CcSEcCtD
Donepezil—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000739	CcSEcCtD
Donepezil—ACHE—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000142	0.00401	CbGpPWpGaD
Donepezil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000738	CcSEcCtD
Donepezil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.00399	CbGpPWpGaD
Donepezil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.000733	CcSEcCtD
Donepezil—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000141	0.000733	CcSEcCtD
Donepezil—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.000733	CcSEcCtD
Donepezil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000141	0.000733	CcSEcCtD
Donepezil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.000732	CcSEcCtD
Donepezil—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000731	CcSEcCtD
Donepezil—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00014	0.00396	CbGpPWpGaD
Donepezil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000727	CcSEcCtD
Donepezil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000725	CcSEcCtD
Donepezil—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000724	CcSEcCtD
Donepezil—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000139	0.00393	CbGpPWpGaD
Donepezil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000722	CcSEcCtD
Donepezil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00072	CcSEcCtD
Donepezil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000138	0.000718	CcSEcCtD
Donepezil—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000718	CcSEcCtD
Donepezil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000137	0.000717	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000137	0.00389	CbGpPWpGaD
Donepezil—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000714	CcSEcCtD
Donepezil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.00388	CbGpPWpGaD
Donepezil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000713	CcSEcCtD
Donepezil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.000711	CcSEcCtD
Donepezil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.00071	CcSEcCtD
Donepezil—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000708	CcSEcCtD
Donepezil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00384	CbGpPWpGaD
Donepezil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000707	CcSEcCtD
Donepezil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000707	CcSEcCtD
Donepezil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.000706	CcSEcCtD
Donepezil—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00382	CbGpPWpGaD
Donepezil—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000704	CcSEcCtD
Donepezil—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000704	CcSEcCtD
Donepezil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000135	0.000703	CcSEcCtD
Donepezil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000701	CcSEcCtD
Donepezil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000701	CcSEcCtD
Donepezil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000699	CcSEcCtD
Donepezil—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000698	CcSEcCtD
Donepezil—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.00379	CbGpPWpGaD
Donepezil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000693	CcSEcCtD
Donepezil—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000693	CcSEcCtD
Donepezil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000132	0.000687	CcSEcCtD
Donepezil—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000687	CcSEcCtD
Donepezil—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000687	CcSEcCtD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000132	0.00373	CbGpPWpGaD
Donepezil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.000681	CcSEcCtD
Donepezil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000131	0.000681	CcSEcCtD
Donepezil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00013	0.000678	CcSEcCtD
Donepezil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.000678	CcSEcCtD
Donepezil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.000678	CcSEcCtD
Donepezil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00013	0.000678	CcSEcCtD
Donepezil—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000676	CcSEcCtD
Donepezil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000129	0.000676	CcSEcCtD
Donepezil—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000671	CcSEcCtD
Donepezil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.00067	CcSEcCtD
Donepezil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.000669	CcSEcCtD
Donepezil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.000669	CcSEcCtD
Donepezil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000128	0.000667	CcSEcCtD
Donepezil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000667	CcSEcCtD
Donepezil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.000666	CcSEcCtD
Donepezil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000666	CcSEcCtD
Donepezil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000127	0.000664	CcSEcCtD
Donepezil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000127	0.000664	CcSEcCtD
Donepezil—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000663	CcSEcCtD
Donepezil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000662	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000126	0.00357	CbGpPWpGaD
Donepezil—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000657	CcSEcCtD
Donepezil—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000655	CcSEcCtD
Donepezil—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000654	CcSEcCtD
Donepezil—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000651	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000125	0.00353	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000123	0.0035	CbGpPWpGaD
Donepezil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000643	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000123	0.00348	CbGpPWpGaD
Donepezil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00064	CcSEcCtD
Donepezil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00064	CcSEcCtD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000121	0.00344	CbGpPWpGaD
Donepezil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000632	CcSEcCtD
Donepezil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000632	CcSEcCtD
Donepezil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000121	0.000631	CcSEcCtD
Donepezil—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00063	CcSEcCtD
Donepezil—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000629	CcSEcCtD
Donepezil—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000625	CcSEcCtD
Donepezil—HTR2A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000119	0.00337	CbGpPWpGaD
Donepezil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000619	CcSEcCtD
Donepezil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000615	CcSEcCtD
Donepezil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000615	CcSEcCtD
Donepezil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000607	CcSEcCtD
Donepezil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000607	CcSEcCtD
Donepezil—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000606	CcSEcCtD
Donepezil—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000606	CcSEcCtD
Donepezil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000603	CcSEcCtD
Donepezil—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000598	CcSEcCtD
Donepezil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000597	CcSEcCtD
Donepezil—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00323	CbGpPWpGaD
Donepezil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000594	CcSEcCtD
Donepezil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000587	CcSEcCtD
Donepezil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000587	CcSEcCtD
Donepezil—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000584	CcSEcCtD
Donepezil—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000582	CcSEcCtD
Donepezil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000581	CcSEcCtD
Donepezil—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00314	CbGpPWpGaD
Donepezil—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000578	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000111	0.00313	CbGpPWpGaD
Donepezil—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00313	CbGpPWpGaD
Donepezil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000575	CcSEcCtD
Donepezil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00311	CbGpPWpGaD
Donepezil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000573	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00011	0.00311	CbGpPWpGaD
Donepezil—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000569	CcSEcCtD
Donepezil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000567	CcSEcCtD
Donepezil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000567	CcSEcCtD
Donepezil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000556	CcSEcCtD
Donepezil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000554	CcSEcCtD
Donepezil—ACHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000105	0.00297	CbGpPWpGaD
Donepezil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000545	CcSEcCtD
Donepezil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000545	CcSEcCtD
Donepezil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000541	CcSEcCtD
Donepezil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000541	CcSEcCtD
Donepezil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000104	0.00054	CcSEcCtD
Donepezil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.00054	CcSEcCtD
Donepezil—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00054	CcSEcCtD
Donepezil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000537	CcSEcCtD
Donepezil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000537	CcSEcCtD
Donepezil—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000537	CcSEcCtD
Donepezil—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000536	CcSEcCtD
Donepezil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000536	CcSEcCtD
Donepezil—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000535	CcSEcCtD
Donepezil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000534	CcSEcCtD
Donepezil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00053	CcSEcCtD
Donepezil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000529	CcSEcCtD
Donepezil—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000528	CcSEcCtD
Donepezil—Depression—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000528	CcSEcCtD
Donepezil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000526	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.0001	0.00285	CbGpPWpGaD
Donepezil—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.99e-05	0.000522	CcSEcCtD
Donepezil—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.94e-05	0.000519	CcSEcCtD
Donepezil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.93e-05	0.00282	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	9.93e-05	0.00281	CbGpPWpGaD
Donepezil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.86e-05	0.000515	CcSEcCtD
Donepezil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.85e-05	0.00279	CbGpPWpGaD
Donepezil—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.83e-05	0.000513	CcSEcCtD
Donepezil—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.8e-05	0.00278	CbGpPWpGaD
Donepezil—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.8e-05	0.000511	CcSEcCtD
Donepezil—HRH3—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	9.79e-05	0.00278	CbGpPWpGaD
Donepezil—Rash—Salbutamol—chronic obstructive pulmonary disease	9.78e-05	0.000511	CcSEcCtD
Donepezil—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.78e-05	0.00051	CcSEcCtD
Donepezil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.77e-05	0.00051	CcSEcCtD
Donepezil—Nausea—Formoterol—chronic obstructive pulmonary disease	9.76e-05	0.000509	CcSEcCtD
Donepezil—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.76e-05	0.000509	CcSEcCtD
Donepezil—Headache—Salbutamol—chronic obstructive pulmonary disease	9.72e-05	0.000507	CcSEcCtD
Donepezil—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.72e-05	0.00275	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.71e-05	0.00275	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.6e-05	0.00272	CbGpPWpGaD
Donepezil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.58e-05	0.0005	CcSEcCtD
Donepezil—Nausea—Montelukast—chronic obstructive pulmonary disease	9.56e-05	0.000499	CcSEcCtD
Donepezil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	9.45e-05	0.000493	CcSEcCtD
Donepezil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.41e-05	0.000491	CcSEcCtD
Donepezil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	9.27e-05	0.000484	CcSEcCtD
Donepezil—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.22e-05	0.000481	CcSEcCtD
Donepezil—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.17e-05	0.000479	CcSEcCtD
Donepezil—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000477	CcSEcCtD
Donepezil—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.14e-05	0.00259	CbGpPWpGaD
Donepezil—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000475	CcSEcCtD
Donepezil—Hallucination—Prednisone—chronic obstructive pulmonary disease	9.06e-05	0.000473	CcSEcCtD
Donepezil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.94e-05	0.00253	CbGpPWpGaD
Donepezil—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.9e-05	0.000464	CcSEcCtD
Donepezil—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.82e-05	0.0025	CbGpPWpGaD
Donepezil—Shock—Prednisolone—chronic obstructive pulmonary disease	8.75e-05	0.000457	CcSEcCtD
Donepezil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.6e-05	0.000449	CcSEcCtD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	8.51e-05	0.00241	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APIP—chronic obstructive pulmonary disease	8.39e-05	0.00238	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	8.23e-05	0.00233	CbGpPWpGaD
Donepezil—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000424	CcSEcCtD
Donepezil—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.05e-05	0.00228	CbGpPWpGaD
Donepezil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.05e-05	0.00042	CcSEcCtD
Donepezil—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.00042	CcSEcCtD
Donepezil—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.03e-05	0.00228	CbGpPWpGaD
Donepezil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.99e-05	0.000417	CcSEcCtD
Donepezil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.98e-05	0.00226	CbGpPWpGaD
Donepezil—Mental disorder—Prednisone—chronic obstructive pulmonary disease	7.97e-05	0.000416	CcSEcCtD
Donepezil—ACHE—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	7.95e-05	0.00225	CbGpPWpGaD
Donepezil—Malnutrition—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000414	CcSEcCtD
Donepezil—Erythema—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000414	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.79e-05	0.00221	CbGpPWpGaD
Donepezil—Pain—Prednisolone—chronic obstructive pulmonary disease	7.61e-05	0.000397	CcSEcCtD
Donepezil—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.47e-05	0.00039	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.36e-05	0.00209	CbGpPWpGaD
Donepezil—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000384	CcSEcCtD
Donepezil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.33e-05	0.000383	CcSEcCtD
Donepezil—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.32e-05	0.000382	CcSEcCtD
Donepezil—Agitation—Prednisone—chronic obstructive pulmonary disease	7.28e-05	0.00038	CcSEcCtD
Donepezil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.25e-05	0.00205	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	7.2e-05	0.00204	CbGpPWpGaD
Donepezil—Malaise—Prednisone—chronic obstructive pulmonary disease	7.14e-05	0.000373	CcSEcCtD
Donepezil—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.12e-05	0.000372	CcSEcCtD
Donepezil—Syncope—Prednisone—chronic obstructive pulmonary disease	7.11e-05	0.000371	CcSEcCtD
Donepezil—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.08e-05	0.00201	CbGpPWpGaD
Donepezil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.07e-05	0.000369	CcSEcCtD
Donepezil—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.02e-05	0.00199	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7e-05	0.00198	CbGpPWpGaD
Donepezil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000363	CcSEcCtD
Donepezil—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.94e-05	0.00197	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.94e-05	0.00197	CbGpPWpGaD
Donepezil—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.86e-05	0.000358	CcSEcCtD
Donepezil—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.000357	CcSEcCtD
Donepezil—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.000352	CcSEcCtD
Donepezil—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.000352	CcSEcCtD
Donepezil—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000351	CcSEcCtD
Donepezil—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000348	CcSEcCtD
Donepezil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.56e-05	0.000342	CcSEcCtD
Donepezil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.49e-05	0.00184	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	6.48e-05	0.00184	CbGpPWpGaD
Donepezil—Oedema—Prednisone—chronic obstructive pulmonary disease	6.47e-05	0.000338	CcSEcCtD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	6.44e-05	0.00183	CbGpPWpGaD
Donepezil—Infection—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.000335	CcSEcCtD
Donepezil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.41e-05	0.00182	CbGpPWpGaD
Donepezil—Shock—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000332	CcSEcCtD
Donepezil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000331	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.3e-05	0.00179	CbGpPWpGaD
Donepezil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000326	CcSEcCtD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	6.23e-05	0.00177	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.2e-05	0.00176	CbGpPWpGaD
Donepezil—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000322	CcSEcCtD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.98e-05	0.0017	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.93e-05	0.00168	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.93e-05	0.00168	CbGpPWpGaD
Donepezil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.89e-05	0.000308	CcSEcCtD
Donepezil—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.89e-05	0.00167	CbGpPWpGaD
Donepezil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.88e-05	0.000307	CcSEcCtD
Donepezil—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.85e-05	0.000305	CcSEcCtD
Donepezil—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.84e-05	0.00165	CbGpPWpGaD
Donepezil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000303	CcSEcCtD
Donepezil—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.81e-05	0.00165	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.76e-05	0.00163	CbGpPWpGaD
Donepezil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.69e-05	0.000297	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.63e-05	0.0016	CbGpPWpGaD
Donepezil—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000293	CcSEcCtD
Donepezil—Rash—Prednisolone—chronic obstructive pulmonary disease	5.61e-05	0.000293	CcSEcCtD
Donepezil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.61e-05	0.000293	CcSEcCtD
Donepezil—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.000291	CcSEcCtD
Donepezil—Headache—Prednisolone—chronic obstructive pulmonary disease	5.57e-05	0.000291	CcSEcCtD
Donepezil—ACHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.56e-05	0.00158	CbGpPWpGaD
Donepezil—Constipation—Prednisone—chronic obstructive pulmonary disease	5.53e-05	0.000289	CcSEcCtD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.51e-05	0.00156	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.42e-05	0.00154	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GC—chronic obstructive pulmonary disease	5.41e-05	0.00153	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.34e-05	0.00151	CbGpPWpGaD
Donepezil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.000278	CcSEcCtD
Donepezil—HTR2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.31e-05	0.0015	CbGpPWpGaD
Donepezil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.29e-05	0.000276	CcSEcCtD
Donepezil—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.29e-05	0.000276	CcSEcCtD
Donepezil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.26e-05	0.00149	CbGpPWpGaD
Donepezil—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.14e-05	0.000268	CcSEcCtD
Donepezil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.000267	CcSEcCtD
Donepezil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.000267	CcSEcCtD
Donepezil—ACHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.03e-05	0.00142	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.94e-05	0.0014	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.93e-05	0.0014	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.91e-05	0.00139	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.87e-05	0.00138	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.84e-05	0.00137	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	4.83e-05	0.00137	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.8e-05	0.00136	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.77e-05	0.00135	CbGpPWpGaD
Donepezil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.000249	CcSEcCtD
Donepezil—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000242	CcSEcCtD
Donepezil—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.63e-05	0.00131	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.58e-05	0.0013	CbGpPWpGaD
Donepezil—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.57e-05	0.000239	CcSEcCtD
Donepezil—HTR2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.54e-05	0.00129	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.51e-05	0.00128	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.5e-05	0.00128	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.49e-05	0.00127	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.47e-05	0.00127	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.45e-05	0.00126	CbGpPWpGaD
Donepezil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.42e-05	0.000231	CcSEcCtD
Donepezil—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.41e-05	0.00125	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	4.34e-05	0.00123	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.34e-05	0.00123	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.32e-05	0.00122	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.28e-05	0.00121	CbGpPWpGaD
Donepezil—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000223	CcSEcCtD
Donepezil—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.24e-05	0.0012	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.22e-05	0.0012	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.18e-05	0.00119	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.12e-05	0.00117	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.12e-05	0.00117	CbGpPWpGaD
Donepezil—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.11e-05	0.000215	CcSEcCtD
Donepezil—Rash—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000213	CcSEcCtD
Donepezil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.000213	CcSEcCtD
Donepezil—HTR2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.06e-05	0.00115	CbGpPWpGaD
Donepezil—Headache—Prednisone—chronic obstructive pulmonary disease	4.05e-05	0.000211	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.04e-05	0.00115	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.03e-05	0.00114	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4e-05	0.00114	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.85e-05	0.00109	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.85e-05	0.00109	CbGpPWpGaD
Donepezil—Nausea—Prednisone—chronic obstructive pulmonary disease	3.84e-05	0.0002	CcSEcCtD
Donepezil—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.8e-05	0.00108	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.72e-05	0.00105	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.66e-05	0.00104	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.65e-05	0.00104	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.63e-05	0.00103	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.44e-05	0.000975	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.41e-05	0.000967	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.39e-05	0.000962	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.35e-05	0.00095	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.33e-05	0.000943	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.32e-05	0.000942	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.22e-05	0.000911	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.21e-05	0.00091	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.17e-05	0.000897	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.13e-05	0.000888	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	3.1e-05	0.00088	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.04e-05	0.000862	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.02e-05	0.000857	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	3e-05	0.000851	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.95e-05	0.000837	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.95e-05	0.000836	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GCLC—chronic obstructive pulmonary disease	2.92e-05	0.000828	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.91e-05	0.000825	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.91e-05	0.000825	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.8e-05	0.000793	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.76e-05	0.000782	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.72e-05	0.000772	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.7e-05	0.000767	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CTGF—chronic obstructive pulmonary disease	2.66e-05	0.000755	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.58e-05	0.000731	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.54e-05	0.000721	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.53e-05	0.000716	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.45e-05	0.000696	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.44e-05	0.000691	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.43e-05	0.000689	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.3e-05	0.000651	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.28e-05	0.000646	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.26e-05	0.000641	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.25e-05	0.000638	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.24e-05	0.000635	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.22e-05	0.00063	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.22e-05	0.000629	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.2e-05	0.000623	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.12e-05	0.000602	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.09e-05	0.000591	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.06e-05	0.000584	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.05e-05	0.000582	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.05e-05	0.00058	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.04e-05	0.000579	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.03e-05	0.000574	CbGpPWpGaD
Donepezil—ACHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.02e-05	0.000572	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2e-05	0.000566	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.96e-05	0.000557	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.96e-05	0.000556	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.96e-05	0.000554	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.88e-05	0.000533	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.86e-05	0.000528	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.8e-05	0.00051	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.78e-05	0.000506	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.71e-05	0.000484	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.000462	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.63e-05	0.000461	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.49e-05	0.000422	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.46e-05	0.000414	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.45e-05	0.000411	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.44e-05	0.000407	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.35e-05	0.000382	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.34e-05	0.00038	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.34e-05	0.000378	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.31e-05	0.000372	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.23e-05	0.000349	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—chronic obstructive pulmonary disease	1.21e-05	0.000344	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.21e-05	0.000343	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.00034	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.2e-05	0.000339	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.000336	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-05	0.000329	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.11e-05	0.000314	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000314	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.1e-05	0.000313	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.1e-05	0.000312	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.00031	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.08e-05	0.000307	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.01e-05	0.000286	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.01e-05	0.000286	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	0.000285	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1e-05	0.000284	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.98e-06	0.000283	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.95e-06	0.000254	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.4e-06	0.000238	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.32e-06	0.000236	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.28e-06	0.000235	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.21e-06	0.000233	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.92e-06	0.000225	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.83e-06	0.000222	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.72e-06	0.000219	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.65e-06	0.000217	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.36e-06	0.000209	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.32e-06	0.000207	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.25e-06	0.000206	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.14e-06	0.000203	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.03e-06	0.000199	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.71e-06	0.00019	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.58e-06	0.000187	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.95e-06	0.000169	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.66e-06	0.00016	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.49e-06	0.000156	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.41e-06	0.000153	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.38e-06	0.000153	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.04e-06	0.000143	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.97e-06	0.000141	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.93e-06	0.00014	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.83e-06	0.000137	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.78e-06	0.000136	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.76e-06	0.000135	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.72e-06	0.000134	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.44e-06	0.000126	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.35e-06	0.000123	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.65e-06	0.000104	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.34e-06	9.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.25e-06	9.22e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.11e-06	8.81e-05	CbGpPWpGaD
